Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000011

Chief Medical Officer sold 20,404 shares at an average $27.93 ($569,809)

  • Chief Medical Officer acquired 14,056 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-02-12 Option exercise 10b5-1 +6,349 $1.08 $6,857 56,786 D
Rodman David Malcom Chief Medical Officer 2026-02-12 Sale 10b5-1 −5,828 $28.94 $168,635 50,958 D
Rodman David Malcom Chief Medical Officer 2026-02-12 Sale 10b5-1 −521 $29.64 $15,442 50,437 D
Rodman David Malcom Chief Medical Officer 2026-02-13 Option exercise 10b5-1 +3,541 $10.20 $36,118 53,978 D
Rodman David Malcom Chief Medical Officer 2026-02-13 Sale 10b5-1 −3,541 $27.33 $96,776 50,437 D
Rodman David Malcom Chief Medical Officer 2026-02-13 Option exercise 10b5-1 +4,166 $14.25 $59,366 54,603 D
Rodman David Malcom Chief Medical Officer 2026-02-13 Sale 10b5-1 −4,166 $27.33 $113,857 50,437 D
Rodman David Malcom Chief Medical Officer 2026-02-13 Sale 10b5-1 −6,348 $27.58 $175,100 44,089 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-02-12 Option exercise · Stock Option 10b5-1 −6,349 31,743 D
Rodman David Malcom Chief Medical Officer 2026-02-13 Option exercise · Stock Option 10b5-1 −3,541 127,501 D
Rodman David Malcom Chief Medical Officer 2026-02-13 Option exercise · Stock Option 10b5-1 −4,166 100,001 D
Open-market sales · 20,404 sh · avg $27.93 · $569,809
Loading xslF345X05/wk-form4_1771028714.xml…